Synthesis and Biological Evaluation of Imidazo‐Thiadiazole‐Linked Benzisoxazole Hybrids as Dual
α
‐Glucosidase and
α
‐Amylase Inhibitors With Antioxidant Potential
Findings suggest that the synthesized hybrids represent promising multifunctional candidates for T2DM therapy, combining potent enzyme inhibition, antioxidant activity, and favorable drug‐like profiles.
Abstract
Type 2 diabetes mellitus (T2DM) remains a major global health challenge, necessitating the discovery of novel therapeutics with improved safety and efficacy. In this study, a series of imidazo‐thiadiazole‐linked benzisoxazoles (
1–20
) was synthesized and evaluated for dual inhibitory activity against
α
‐glucosidase and
α
‐amylase enzymes. Most compounds showed potent enzyme inhibition, with compounds
3
and
4
exhibiting superior activity against
α
‐glucosidase and
α
‐amylase (IC
50
= 1.56 and 3.01 µM for compound
3
; IC
50
= 3.24 and 5.82 µM for compound
4
) compared to the standard drug acarbose (IC
50
= 14.85 and 15.25 µM). Enzyme kinetic studies revealed both competitive and uncompetitive modes of inhibition. Structure–activity relationship (SAR) analysis highlighted that
para
‐substituted electron‐withdrawing groups significantly enhanced inhibitory potential. Antioxidant activity was assessed using cupric reducing antioxidant capacity (CUPRAC), ferric reducing antioxidant power (FRAP), and 1,1‐diphenyl‐2‐picrylhydrazyl (DPPH) assays, with compound
2
displaying the strongest effect. Molecular docking supported the in vitro results, revealing favorable interactions with key catalytic residues of target enzymes. ADME/T profiling confirmed desirable pharmacokinetic properties and drug‐likeness. Overall, these findings suggest that the synthesized hybrids represent promising multifunctional candidates for T2DM therapy, combining potent enzyme inhibition, antioxidant activity, and favorable drug‐like profiles.
Interestingly, compounds 7a and 8a exhibited five‐fold higher selectivity for BChE than AChE, suggesting their potential relevance for further exploration in the context of Alzheimer's disease therapeutics.
Dilan Konyar, Hayati Okur, M. T. Muhammed et al.· ChemistrySelect· 0 citations
The synthesized sulfonamide derivatives are identified as promising scaffolds for the further development of multifunctional cholinesterase and carbonic anhydrase inhibitors and potential limitations associated with higher polarity, limited predicted blood–brain barrier penetration, and predicted toxicity risks are ide...
Gülnur Arslan Karahan, Başak Gökçe, M. T. Muhammed et al.· Drug development research (P...· 0 citations
The hybrids presented here represent promising multifunctional leads with antibacterial, antioxidant, anti‐inflammatory, and drug‐like properties, including Lipinski compliance, high GI absorption, no BBB penetration, and low predicted toxicity.
Mlis Belete, Endale Mulugeta, Daniel Rentsch et al.· ChemistryOpen· 0 citations
SJ2 is a promising lead for α‐amylase inhibition, which needs further optimization and biological validation, and future evaluation against α‐glucosidase and relevant in vivo models will be essential to determine the more general antidiabetic potential of this scaffold.
Sahil Jaidka, Ankush Kumar, Christopher Basumatary et al.· Chemistry and Biodiversity· 0 citations
To discover novel green antifungal candidates, 20 3‐acylaminoisoquinoline derivatives were designed and synthesized by introducing the active fragment phenoxypyridine. Their structures were verified by 1H NMR, 13C NMR, and HRMS. The structure of compound X9 was further confirmed via X‐ray crystallography. Their antifun...
Jia-Yao Zhang, Shuai-Peng Sun, Ya-Jing Guo et al.· Chemistry and Biodiversity· 0 citations
Alzheimer’s disease (AD), involves progressive cognitive impairment primarily associated with cholinergic dysfunction. Dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) continue to represent a validated and clinically relevant therapeutic approach for alleviating cholinergic deficits in...
Y. Khan, Hina Sarfraz, Azmatullah Khan et al.· Journal of Computational Bio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.